352209-87-1

Basic information

• Product Name: Benzenesulfonic acid, 4-butoxy-, sodium salt
• CAS NO: 352209-87-1
• Molecular Formula: C10H14O4S.Na
• Molecular Weight: 252.267
• Mol File: 352209-87-1.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: Benzenesulfonic acid, 4-butoxy-, sodium salt(CAS DataBase Reference)
• NIST Chemistry Reference: Benzenesulfonic acid, 4-butoxy-, sodium salt(352209-87-1)
• EPA Substance Registry System: Benzenesulfonic acid, 4-butoxy-, sodium salt(352209-87-1)

Safety Data

• Hazardous Substances Data: 352209-87-1(Hazardous Substances Data)

Upstream product

• 109-65-9 1-bromo-butane 
• 825-90-1 sodium p-hydroxybenzenesulfonate 

Downstream Products

• 880139-14-0 N-(2-(1H-indol-3-yl)ethyl)-4-butoxybenzenesulfonamide 
• 1138-56-3 4-butoxybenzene-sulfonyl chloride 

Relevant articles and documents

CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE

Described herein are compounds, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or disorders associated with the enzyme ceramide galactosyltransferase (CGT), such as, for example, lysosomal storage diseases. Examples of lysosomal storage diseases include, for example, Krabbe disease and Metachromatic Leukodystrophy.

Method for preparing alpha-sulfonyl hydroxamic acid derivatives

Compounds of the formula: that can be important as matrix metalloproteinase (MMP) and TNF-alpha converting enzyme (TACE) inhibitors, phosphodiesterase inhibitors, renin inhibitors, antithrombotics, and 5-lipoxygenase inhibitors are prepared by novel methods of the present invention.